Fetal monitoring in high-risk pregnancy.
D000698:Analgesia / Q000009:adverse effects; D000758:Anesthesia / Q000009:adverse effects; D000773:Anesthesia, Obstetrical; D001034:Apgar Score; D004562:Electrocardiography; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000503:physiopathology; D005318:Fetal Heart / Q000187:drug effects / Q000503:physiopathology*; D005333:Fetus / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D007751:Labor, Induced; D009921:Metaproterenol / Q000494:pharmacology; D008991:Monitoring, Physiologic / Q000295:instrumentation; D010100:Oxygen / Q000494:pharmacology; D010121:Oxytocin / Q000008:administration & dosage / Q000494:pharmacology; D011187:Posture; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis*; D013997:Time Factors; D014599:Uterus / Q000187:drug effects
D010121:Oxytocin; D009921:Metaproterenol; D010100:Oxygen